Cancer Research UK find Key to Drug Resistant Bowel Cancer

Blocking a molecule could bypass bowel cancer’s defense against the drug cetuximab, according to new research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool.   “Understanding the mechanisms that bowel cancer cells use to evade treatment with cetuximab will help us find ways to delay or prevent it recurring. This will help more…